Medicinal Research Reviews

Papers
(The H4-Index of Medicinal Research Reviews is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
174
153
Design, synthesis, and applications of ring‐functionalized histidines in peptide‐based medicinal chemistry and drug discovery153
Indirect influence on the BDNF/TrkB receptor signaling pathway via GPCRs, an emerging strategy in the treatment of neurodegenerative disorders146
Decoding Gene Expression Changes in Cerebral Tumors: Before and After Radiotherapy139
Galectin‐8 inhibition and functions in immune response and tumor biology118
103
Key characters of glycodrugs101
Next generation of boron neutron capture therapy (BNCT) agents for cancer treatment95
New drug approvals for 2022: Synthesis and clinical applications94
The role and prospect of lysine‐specific demethylases in cancer chemoresistance84
Nanotechnology‐based electrochemical biosensors for monitoring breast cancer biomarkers79
Front Cover Image, Volume 45, Issue 171
Rethinking therapeutic strategies of dual‐target drugs: An update on pharmacological small‐molecule compounds in cancer70
Current and emerging approaches to noncompetitive AR inhibition69
Pathophysiological significance and modulation of the transient receptor potential canonical 3 ion channel68
A Focus on Natural Autophagy Modulators as Potential Host‐Directed Weapons Against Emerging and Re‐Emerging Viruses68
Targeting Histone H3K9 Methyltransferase G9a as a Potential Therapeutic Strategy for Neuropsychiatric Disorders67
Metal complexes bearing EGFR‐inhibiting ligands as promising anticancer agents63
Advances in ameliorating inflammatory diseases and cancers by andrographolide: Pharmacokinetics, pharmacodynamics, and perspective59
The ethnomedicinal and functional uses, phytochemical and pharmacology of compounds from Ardisia species: An updated review57
α‐Synuclein in Parkinson's Disease: From Bench to Bedside55
Mechanism and application of β‐adrenoceptor blockers in soft tissue wound healing54
An overview of sphingosine‐1‐phosphate receptor 2: Structure, biological function, and small‐molecule modulators52
Emerging roles of nerve‐bone axis in modulating skeletal system50
Polymer nanotherapeutics: A promising approach toward microglial inhibition in neurodegenerative diseases50
Mitochondrial quality control proteases and their modulation for cancer therapy49
Current nanocomposite advances for biomedical and environmental application diversity46
Enhancing healthy aging with small molecules: A mitochondrial perspective43
Targeting lysosomal quality control as a therapeutic strategy against aging and diseases40
Issue Information39
Inside Front Cover Image, Volume 44, Issue 535
Issue Information35
Mechanism of epithelial‐mesenchymal transition in cancer and its regulation by natural compounds35
Advances in reversible covalent kinase inhibitors35
Novel druggable mechanism of Parkinson's disease: Potential therapeutics and underlying pathogenesis based on ferroptosis35
0.38667392730713